Sedana Medical AB (publ) (SEDANA) Q3 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Hello everyone, and welcome to today's Finwire webcast presentation with Sedona Medical. With us presenting today, we have the CEO, Johannes Dahl, CFO, Johan Spets, and CMO, Peter Säcke. We'll do a Q&A after the presentation. You can either type in your questions using the form to the right, or if you're calling in and would like to ask a question, please press star 9. to raise your hand and start 60 on mute when you get the word. And with that said, please go ahead with your presentation. Thank you for the introduction and welcome to our Q3 report presentation today. Let's dive straight in on page three with the highlights of the quota, please. Thank you. The short version of this report is this. If I compare to the analyst expectations ahead of the report, sales have come in lower than expectations, also lower than our own ambitions today. But despite that shortfall in sales, our bottom line was actually better than people expected. Year to date, we are still showing a profitable XUS business, and I'm very confident that we will deliver on our financial guidance for the full year. And this is exactly what I am hoping you will take away from today's call. We have now reached a scale and put in place a... cost structure that allows us to keep our ex-US EBITDA in the positive territory even when we have quarters like this one where market circumstances lead to no or quite low growth. Because the truth is this, our business is subject to seasonal swings every year and sometimes these seasonal swings differ quite a bit between years. Sometimes this will be in our favor. And from time to time, as we see it today, we will see quarters like this one where we have much less patients with respiratory problems in the ICUs, which will then affect our sales. What is important f...